Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2- Positive Advanced Solid Tumors Excluding Breast Cancer

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) is a member of the ErbB family and is a key proto-oncogene in solid tumors. This pilot study investigated the safety and efficacy of pyrotinib in HER2-positive non-breast advanced solid tumors. PATIENTS AND METHODS: Twenty-five patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yuzhen, Yang, Hui, Liu, Zhuo, Tan, Jie, Zhu, Chunrong, Chen, Minbin, Zhou, Rengui, Wang, Lei, Qian, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779303/
https://www.ncbi.nlm.nih.gov/pubmed/33408520
http://dx.doi.org/10.2147/CMAR.S281765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779303/
https://www.ncbi.nlm.nih.gov/pubmed/33408520
http://dx.doi.org/10.2147/CMAR.S281765

Ejemplares similares